Figures & data
Figure 1 Schematic diagram showing different kinds of drug-loaded emulsions classified by their dispersed and continuous phases: oil-in-water (O/W), water-in-oil (W/O), and water-in-oil-in-water (W/O/W).
![Figure 1 Schematic diagram showing different kinds of drug-loaded emulsions classified by their dispersed and continuous phases: oil-in-water (O/W), water-in-oil (W/O), and water-in-oil-in-water (W/O/W).](/cms/asset/a49ea0b2-d615-49d7-be48-260702264a38/dijn_a_12159559_f0001_c.jpg)
Figure 2 Re-188-ECD Lipiodol® emulsion with thermal responsive characteristic, (A) thermal responsive triblock copolymer emulsifier, (B) Illustration of the emulsion preparation, (C) Re-188-ECD Lipiodol® targeting N1-S1 hepatoma-bearing rats.
![Figure 2 Re-188-ECD Lipiodol® emulsion with thermal responsive characteristic, (A) thermal responsive triblock copolymer emulsifier, (B) Illustration of the emulsion preparation, (C) Re-188-ECD Lipiodol® targeting N1-S1 hepatoma-bearing rats.](/cms/asset/16b798c5-f656-4b11-b840-cc02faa65c2f/dijn_a_12159559_f0002_c.jpg)
Figure 3 Perfluoro carbon (PFC) encapsulated emulsion with different emulsifiers (graphene oxide (GO), sodium dodecyl sulfate (SDS), and TWEEN20).
![Figure 3 Perfluoro carbon (PFC) encapsulated emulsion with different emulsifiers (graphene oxide (GO), sodium dodecyl sulfate (SDS), and TWEEN20).](/cms/asset/b8edb381-4478-4392-ab8f-2ce0ca233c62/dijn_a_12159559_f0003_c.jpg)
Figure 4 (a) preparation of bioinspired perfluorocarbon-based oxygen carriers with concave shape and deformable shell consisting of 1) Shirasu porous glass (SPG) emulsification to generate size-controlled emulsion, 2) evaporation-induced phase separation to form spherical and deformable PFC-based OCs (DFCs), and 3) solvent-induced shape change to obtain the “concave-shaped” DFCs (cDFCs) and (b) SEM images of DFCs, cDFCs, and human red blood cell (hRBC).
![Figure 4 (a) preparation of bioinspired perfluorocarbon-based oxygen carriers with concave shape and deformable shell consisting of 1) Shirasu porous glass (SPG) emulsification to generate size-controlled emulsion, 2) evaporation-induced phase separation to form spherical and deformable PFC-based OCs (DFCs), and 3) solvent-induced shape change to obtain the “concave-shaped” DFCs (cDFCs) and (b) SEM images of DFCs, cDFCs, and human red blood cell (hRBC).](/cms/asset/cf014b7f-1320-4812-8553-b5cf4ff3d67d/dijn_a_12159559_f0004_c.jpg)
Figure 5 Ga-67 and 68-radiolabeled sphingomyelin nanoemulsions using DTPA-PE and NOTA-SA as chelating ligand for PET and SPECT imaging and the demonstration of nanoemulsions surface modification by polyethylene glycol (PEG) and hyaluronic acid.
![Figure 5 Ga-67 and 68-radiolabeled sphingomyelin nanoemulsions using DTPA-PE and NOTA-SA as chelating ligand for PET and SPECT imaging and the demonstration of nanoemulsions surface modification by polyethylene glycol (PEG) and hyaluronic acid.](/cms/asset/bee2d4cf-09bf-489b-9459-559deeeeaa8e/dijn_a_12159559_f0005_c.jpg)